SCHEMBL6923666

SCHEMBL6923666

Cc1ccc2c(c1)c1c(OCC#N)cccc1n2Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.44
LMNA P02545 1/20 0.44
PDE9A O76083 1/20 0.41
PDE1C Q14123 1/20 0.41
PLA2G2A P14555 7/20 0.41
CYP19A1 P11511 1/20 0.40
ALDH1A1 P00352 3/20 0.40
HTT P42858 1/20 0.40
PLA2G10 O15496 1/20 0.40
PLA2G1B P04054 1/20 0.40
PLA2G5 P39877 1/20 0.40
PLA2G2E Q9NZK7 1/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
P2RX4 Q99571 1/20 0.40
MEN1 O00255 3/20 0.39
MIF P14174 1/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924426 0.87 TSHR (0.47) KMT2APLA2G2APLA2G1BMAPTTSHR
SCHEMBL6923328 0.83 PLA2G2A (0.45) KMT2ALMNAPLA2G2ACYP19A1ALDH1A1
SCHEMBL6926722 0.81 HTR6 (0.48) KMT2ALMNAPLA2G2ACYP19A1PLA2G10
SCHEMBL6919685 0.81 PLA2G2A (0.44) KMT2APLA2G2AALDH1A1HTTPLA2G10
SCHEMBL6925514 0.81 MAPK1 (0.48) KMT2ALMNAPLA2G2AALDH1A1HTT
SCHEMBL6920472 0.79 PLA2G2A (0.56) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E
SCHEMBL6920470 0.78 HTR6 (0.52) KMT2ALMNAPLA2G2AALDH1A1PLA2G10
SCHEMBL6921062 0.76 MAPT (0.39) KMT2ALMNAPLA2G2ACYP19A1ALDH1A1
SCHEMBL6923659 0.76 KMT2A (0.51) KMT2ALMNAPLA2G2ACYP19A1ALDH1A1
SCHEMBL679026 0.75 KMT2A (0.64) KMT2ALMNACYP19A1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed